Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Analytical Instrument Qualification with Data Integrity in Mind

Technical notes

| 2022 | Waters

Software

Instrumentation

Software

Manufacturer

Waters

Industries

Pharma & Biopharma

Analytical Instruments Solutions for Seized Drugs

Brochures and specifications

| 2020 | Shimadzu

GC, GC/MSD, HPLC, LC/MS, SFC, LC/SQ

Instrumentation

GC, GC/MSD, HPLC, LC/MS, SFC, LC/SQ

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Impact of USP <1058> - Regulatory Spotlight on Analytical Instrument Qualification (AIQ)

Technical notes

| 2017 | Agilent Technologies

GC, GC/MSD, HPLC, LC/MS, SFC

Instrumentation

GC, GC/MSD, HPLC, LC/MS, SFC

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

USP <467> Headspace Residual Solvent Assay with a HT3™ Headspace Instrument

Applications

| 2010 | Tekmar Teledyne

GC, HeadSpace

Instrumentation

GC, HeadSpace

Manufacturer

Shimadzu, Tekmar Teledyne

Industries

Pharma & Biopharma

Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

Guides

| 2010 | Agilent Technologies

GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS

Instrumentation

GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation

Applications

| 2020 | Agilent Technologies

GC/MSD, GC/MS/MS, GC/QQQ

Instrumentation

GC/MSD, GC/MS/MS, GC/QQQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

MSUM: Solution for Extractables & Leachables Analysis - Instruments, Software, Database/Spectral Library

Presentations

| 2017 | Thermo Fisher Scientific

GC/MSD, GC/MS/MS, GC/HRMS, GC/SQ, GC/QQQ, GC/Orbitrap, Software, HPLC, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, LC/QQQ

Instrumentation

GC/MSD, GC/MS/MS, GC/HRMS, GC/SQ, GC/QQQ, GC/Orbitrap, Software, HPLC, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, LC/QQQ

Manufacturer

Thermo Fisher Scientific

Industries

Pharma & Biopharma

Screening of Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation

Applications

| 2023 | Agilent Technologies

GC/MSD, GC/MS/MS, GC/QQQ

Instrumentation

GC/MSD, GC/MS/MS, GC/QQQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation

Applications

| 2020 | Agilent Technologies

GC/MSD, GC/MS/MS, GC/QQQ

Instrumentation

GC/MSD, GC/MS/MS, GC/QQQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

System Suitability Tests and AIQ

Others

| 2010 | PerkinElmer

Instrumentation

Manufacturer

PerkinElmer

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Analytical Instrument Qualification with Data Integrity in Mind

Analytical Instruments Solutions for Seized Drugs

Impact of USP <1058> - Regulatory Spotlight on Analytical Instrument Qualification (AIQ)

USP <467> Headspace Residual Solvent Assay with a HT3™ Headspace Instrument

Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation

MSUM: Solution for Extractables & Leachables Analysis - Instruments, Software, Database/Spectral Library

Screening of Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation

Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation

System Suitability Tests and AIQ

Related content

Scientists continue to push the boundaries of imaging techniques and reveal the mysterious world of molecules

Preventing early-onset colorectal cancers aim of $25 million award

New Research Reveals Pesticide Mixtures Widespread in Environment, Urging Enhanced Regulatory Measures